Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.43.3.603
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 1999
Authors
Publisher
American Society for Microbiology